Cargando…
The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391055/ https://www.ncbi.nlm.nih.gov/pubmed/33119447 http://dx.doi.org/10.18553/jmcp.2020.26.11.1456 |
| _version_ | 1785082614663610368 |
|---|---|
| author | Agboola, Foluso Atlas, Steven J Touchette, Daniel R Borrelli, Eric P Rind, David M Pearson, Steven D |
| author_facet | Agboola, Foluso Atlas, Steven J Touchette, Daniel R Borrelli, Eric P Rind, David M Pearson, Steven D |
| author_sort | Agboola, Foluso |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10391055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103910552023-08-02 The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council Agboola, Foluso Atlas, Steven J Touchette, Daniel R Borrelli, Eric P Rind, David M Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2020-11 /pmc/articles/PMC10391055/ /pubmed/33119447 http://dx.doi.org/10.18553/jmcp.2020.26.11.1456 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Agboola, Foluso Atlas, Steven J Touchette, Daniel R Borrelli, Eric P Rind, David M Pearson, Steven D The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title | The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full | The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_fullStr | The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full_unstemmed | The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_short | The effectiveness and value of novel acute treatments for migraine: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_sort | effectiveness and value of novel acute treatments for migraine: a summary from the institute for clinical and economic review’s midwest comparative effectiveness public advisory council |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391055/ https://www.ncbi.nlm.nih.gov/pubmed/33119447 http://dx.doi.org/10.18553/jmcp.2020.26.11.1456 |
| work_keys_str_mv | AT agboolafoluso theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT atlasstevenj theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT touchettedanielr theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT borrelliericp theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT rinddavidm theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend theeffectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT agboolafoluso effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT atlasstevenj effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT touchettedanielr effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT borrelliericp effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT rinddavidm effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend effectivenessandvalueofnovelacutetreatmentsformigraineasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil |